FAM3D and colitis: Both WT and Fam3D−/− mice that received Adv-FAM3D demonstrated a significant improvement in the severity of colitis including body weight and colon length over the 7-day DSS treatment, in contrast to Adv-null treatment of mouse colon (Fig. 5b, c).